Search results for " Bipolar disorder"

showing 10 items of 33 documents

Structural brain correlates of IQ changes in bipolar disorder

2006

Background. There is increasing evidence that cognitive deficits are present in bipolar disorder (BP), but their neural correlates have not been fully explored. The aim of this study is to correlate structural brain abnormalities with cognitive performance in BP and to explore differences between clinical subtypes. Method. Thirty-six BP patients (13 men, 23 women) with a mean age of 39 years (range 21–63 years) underwent neuropsychological testing and imaging. Twenty-five patients had bipolar disorder I (BP I) and 11 had bipolar disorder II (BP II). Patients with co-morbid psychiatric diagnosis, drug and alcohol abuse or systemic illness were excluded. Correlations between cognitive perform…

AdultMalemedicine.medical_specialtyBipolar DisorderIntelligenceNeuropsychological TestsSuperior temporal gyrusGyrusInternal medicinemedicineHumansBipolar disorderEffects of sleep deprivation on cognitive performanceApplied PsychologyDepression (differential diagnoses)Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaIntelligence quotientBrainMiddle AgedImage Enhancementmedicine.diseaseMagnetic Resonance ImagingUncusPsychiatry and Mental healthmedicine.anatomical_structureMultivariate AnalysisCardiologyRegression AnalysisFemaleIQ bipolar disordermedicine.symptomCognition DisordersPsychologyManiaNeurosciencePsychological Medicine
researchProduct

Psychopharmacological treatment of bipolar disorder in Latin American

2011

Abstract Objective This study assessed the treatment preferences among Latin American psychiatrists for their bipolar disorder patients and if these preferences reflect the current guidelines. Methods We designed a survey comprised of 14 questions. All the questions were aimed at the treatment of bipolar I patients only. We distributed the survey by hand or e-mail to psychiatrists in eight different countries: Argentina, Brazil, Colombia, Costa Rica, Ecuador, Mexico, Peru and Venezuela. Between May 2008 and June 2009, we were able to gather 1143 surveys. Results As the initial choice of treatment for a bipolar patient who debuts with mania, 61.3% choose a combination of an atypical antipsyc…

Olanzapinemedicine.medical_specialtybusiness.industrymedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticMood stabilizerGeneral MedicineLamotriginemedicine.diseasebehavioral disciplines and activitiesTreatment of bipolar disordermental disordersMedicineBipolar disordermedicine.symptombusinessPsychiatryAntipsychoticManiamedicine.drugClinical psychologyRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct

The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions

2017

Cardio-vascular diseases (CVDs) and CVD-related disorders (including cerebrovascular diseases; CBVDs) are a major public health concern as they represent the leading cause of mortality and morbidity in developed countries. Patients with CVDs and CBVDs co-morbid with mood disorders, especially bipolar disorder (BD) and major depressive disorder (MDD), suffer reduced quality-of-life and significant disability adjusted for years of life and mortality. The relationship between CVDs/CBVDs and mood disorders is likely to be bidirectional. Evidence for shared genetic risk of pathways involved in stress reaction, serotonin or dopamine signalling, circadian rhythms, and energy balance was reported i…

cognitionmedicine.medical_specialtyPsychological interventionphysical activity03 medical and health sciences0302 clinical medicineNeurobiologycardiovascular diseasemental disordersmedicineHumansBipolar disorderPsychiatrybipolar disorderpsychopharmacologyexerciseMood DisordersDepression; bipolar disorder; cardiovascular disease; cognition; comorbidity; exercise; physical activity; psychopharmacology; quality-of-life; strokeDepressionmedicine.diseaseComorbiditystroke030227 psychiatryCerebrovascular DisordersPsychiatry and Mental healthcomorbidityMoodHypomaniaMood disordersquality-of-lifeMajor depressive disordermedicine.symptomPsychologybipolar disorder; cardiovascular disease; cognition; comorbidity; Depression; exercise; physical activity; psychopharmacology; quality-of-life; strokeMania030217 neurology & neurosurgeryClinical psychology
researchProduct

Clinical risk factors for bipolar disorders: A systematic review of prospective studies

2014

Background: Early phases and suspected precursor states of bipolar disorder are not well characterized. We evaluate the prevalence, duration, clinical features and predictive value of non-affective psychopathology as clinical risk factors for bipolar disorder in prospective studies. Methods: We screened PubMed, CINAHL, PsycINFO, Embase, SCOPUS, and ISI-Web of Science databases from inception up to January 31, 2014, following PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and searched: bipolar disorder AND [antecedentn OR predictn OR prodromn OR prospectn OR riskn] AND [diagnosis OR development]. We included only English language reports on prospective…

medicine.medical_specialtyComorbidityImpulsivityTreatment of bipolar disorderchild; prodrome; adolescent; bipolar disorder; risk factor; depressionPrevalence of mental disordersRisk Factorsmental disordersPrevalencemedicineHumansProspective StudiesBipolar disorderRisk factorPsychiatryRetrospective Studiesbipolar disorderchildmedicine.diseaseAnxiety DisordersprodromePsychiatry and Mental healthClinical PsychologySystematic reviewrisk factorAttention Deficit Disorder with HyperactivityadolescentImpulsive BehaviordepressionPanic DisorderAnxietyFemaleCrimemedicine.symptomPsychologyPsychopathologyClinical psychologyJournal of Affective Disorders
researchProduct

Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder

2013

Lithium is the mainstay for the treatment of bipolar disorder (BD) and inhibits glycogen synthase kinase 3-beta (GSK3-beta). The less active GSK3-beta promoter gene variants have been associated with less detrimental clinical features of BD. GSK3-beta gene variants and lithium can influence brain gray matter structure in psychiatric conditions. Diffusion tensor imaging (DTI) measures of white matter (WM) integrity showed widespred disruption of WM structure in BD. In a sample of 70 patients affected by a major depressive episode in course of BD, we investigated the effect of ongoing long-term lithium treatment and GSK3-beta promoter rs334558 polymorphism on WM microstructure, using DTI and …

AdultMaleCorpus callosumNerve Fibers MyelinatedWhite matterGlycogen Synthase Kinase 3GSK3-β03 medical and health sciences0302 clinical medicineCorona radiataFasciculusmedicineHumansInferior longitudinal fasciculusPromoter Regions GeneticGSK3-β; lithium; bipolar disorder; white matter; cingulum bundle030304 developmental biologybipolar disorderPharmacology0303 health sciencesGlycogen Synthase Kinase 3 betabiologyGenetic VariationMiddle Agedbiology.organism_classification3. Good healthPsychiatry and Mental healthmedicine.anatomical_structurenervous systemlithiumCorticospinal tractSettore BIO/14 - FarmacologiaGSK3-beta lithium bipolar disorder white matter cingulum bundleFemaleOriginal ArticleBrain Gray Mattercingulum bundlePsychologywhite matterNeuroscience030217 neurology & neurosurgeryDiffusion MRI
researchProduct

Disruption of White Matter Integrity in Bipolar Depression as a Possible Structural Marker of Illness

2011

Background: Diffusion tensor imaging allows the study of integrity of white matter (WM) tracts. Literature suggests that WM integrity could be altered in bipolar disorder. Heterogeneity of brain imaging methods, the studied samples, and drug treatments make localization, nature, and severity of the WM abnormalities unclear. Methods: We applied tract-based spatial statistics of diffusion tensor imaging measures to compare fractional anisotropy (FA), mean, and radial diffusivity of the WM skeleton in a group of 40 consecutively admitted inpatients affected by a major depressive episode without psychotic features with a diagnosis of bipolar disorder type I and 21 unrelated healthy volunteers f…

AdultMalemedicine.medical_specialtyBipolar DisorderGenu of the corpus callosumImage ProcessingPopulationSpleniumCorpus callosumNerve Fibers MyelinatedWhite matter03 medical and health sciencesComputer-AssistedNerve Fibers0302 clinical medicineInternal medicineFractional anisotropyImage Processing Computer-AssistedmedicineHumanseducationBiological PsychiatryBrain Mappingeducation.field_of_studyAdult; Anisotropy; Bipolar Disorder; pathology; Brain Mapping; Brain; Diffusion Tensor Imaging; Female; Humans; Image Processing; Computer-Assisted; Male; Middle Aged; Nerve Fibers; MyelinatedSuperior longitudinal fasciculusBrainMiddle Aged030227 psychiatry3. Good healthDiffusion Tensor Imagingmedicine.anatomical_structureCardiologyMyelinatedAnisotropypathologyFemalePsychologyNeuroscience030217 neurology & neurosurgeryDiffusion MRIBiological Psychiatry
researchProduct

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analys…

2017

People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta-analysis is lacking. We conducted a large-scale meta-analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD-related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4-13.3). Adjusting for a median of seven confounders, patients had significantly higher o…

medicine.medical_specialtyCardiovascular disease; bipolar disorder; cerebrovascular disease; congestive heart failure; coronary heart disease; major depression; premature mortality; schizophrenia; severe mental illness03 medical and health sciences0302 clinical medicinesevere mental illnessMedicineCardiovascular disease severe mental illness schizophrenia bipolar disorder major depression coronary heart disease cerebrovascular disease congestive heart failure premature mortalitycoronary heart diseasePsychiatrybipolar disorderFramingham Risk Scorebusiness.industryVascular diseaseIncidence (epidemiology)Hazard ratioCorrectionOdds ratiomedicine.diseaseCardiovascular disease030227 psychiatrycerebrovascular diseaseschizophreniaPsychiatry and Mental healthcongestive heart failurepremature mortalityHeart failureMajor depressive disorderPshychiatric Mental Healthbusinessmajor depressionBody mass index030217 neurology & neurosurgery
researchProduct

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-…

2016

ObjectivesTo meta-analytically summarize lamotrigine’s effectiveness and safety in unipolar and bipolar depression.MethodsWe conducted systematic PubMed and SCOPUS reviews (last search =10/01/2015) of randomized controlled trials comparing lamotrigine to placebo or other agents with antidepressant activity in unipolar or bipolar depression. We performed a random-effects meta-analysis of depression ratings, response, remission, and adverse effects calculating standardized mean difference (SMD) and risk ratio (RR) ±95% confidence intervals (CIs).ResultsEighteen studies (n=2152, duration=9.83 weeks) in patients with unipolar depression (studies=4, n=187; monotherapy vs lithium=1, augmentation …

Olanzapinemedicine.medical_specialtyBipolar DisorderLithium (medication)Bipolar depressionBipolar depression bipolar disorder lamotrigine major depressive disorder trials unipolar depressionCitalopramLithiumCitalopramLamotrigineLamotriginePlaceboBipolar depression; bipolar disorder; lamotrigine; major depressive disorder; trials; unipolar depressionBenzodiazepines03 medical and health sciences0302 clinical medicineAntimanic AgentsFluoxetineInternal medicinemedicineHumansBipolar disorderunipolar depressionPsychiatryDepressive Disorder MajorFluoxetinemajor depressive disorderDepressionTriazinesbusiness.industrytrialsmedicine.diseaseAntidepressive Agents030227 psychiatryDrug CombinationsPsychiatry and Mental healthVitamin B ComplexMajor depressive disorderAnticonvulsantsNeurology (clinical)businessInositol030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drug
researchProduct

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants

2018

Abstract Background Treatment-emergent affective switch (TEAS), including treatment-emergent mania (TEM), carry significant burden in the clinical management of bipolar depression, whereas the use of antidepressants raises both efficacy, safety and tolerability concerns. The present study assesses the prevalence and clinical correlates of TEM in selected sample of Bipolar Disorder (BD) Type-II (BD-II) acute depression outpatients. Methods Post-hoc analysis of the clinical and psychopathological features associated with TEM among 91 BD-II depressed outpatients exposed to antidepressants. Results Second-generation antipsychotics (SGA) (p = .005), lithium (≤ .001), cyclothymic/irritable/hypert…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentLithium (medication)media_common.quotation_subjectTreatment-emergent-maniaAntidepressantGastroenterologyYoung Adult03 medical and health sciencesBipolar Disorder (BD) Antidepressant Depression Treatment-emergent-mania0302 clinical medicineInternal medicineRecall biasOutpatientsmedicineHumansBipolar disorderAgedmedia_commonAntidepressant; Bipolar Disorder (BD); Depression; Treatment-emergent-mania; Clinical Psychology; Psychiatry and Mental Healthbusiness.industryDepressionMiddle Agedmedicine.diseaseBipolar Disorder (BD)Antidepressive Agents030227 psychiatryClinical PsychologyCross-Sectional StudiesTreatment OutcomeTolerabilityPsychiatry and Mental HealthAntidepressantDrug Therapy CombinationFemaleTemperamentmedicine.symptombusinessMania030217 neurology & neurosurgeryAntipsychotic AgentsPsychopathologymedicine.drug
researchProduct

Impaired conflict resolution and vigilance in euthymic bipolar disorder.

2015

Abstract Difficulty attending is a common deficit of euthymic bipolar patients. However, it is not known whether this is a global attentional deficit or relates to a specific attentional network. According to the attention network approach, attention is best understood in terms of three functionally and neuroanatomically distinct networks-alerting, orienting, and executive control. In this study, we explored whether and which of the three attentional networks are altered in euthymic Bipolar Disorder (BD). A sample of euthymic BD patients and age-matched healthy controls completed the Attention Network Test for Interactions and Vigilance (ANTI-V) that provided not only a measure of orienting…

AdultMalemedicine.medical_specialtyBipolar Disordermedia_common.quotation_subjectAudiologyalerting; attention network test (ant); bipolar disorders; executive control; orienting; vigilance; psychiatry and mental health; biological psychiatryExecutive Functionbiological psychiatryvigilanceOrientationConflict resolutionattention network test (ant)medicineReaction TimeHumansAttentionBipolar disordermedia_commonNegotiatingorientingAttentional controlComplete remissionIndependent measureCognitionMiddle Agedmedicine.diseaseFunctional recoverypsychiatry and mental healthAffectexecutive controlbipolar disordersalertingFemalePsychologyArousalCognitive psychologyVigilance (psychology)Psychiatry research
researchProduct